SCYNEXIS (STU:135) Cyclically Adjusted FCF per Share: €-44.26 (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

STU:135 SCYNEXIS Inc STU:135
40 GF Score
Price €4.84
GF Value €16.22
! 3 Warning Signs
View Full Analysis

What is SCYNEXIS Cyclically Adjusted FCF per Share?

SCYNEXIS STU:135 40 Cyclically Adjusted FCF per Share is €-44.26 as of Jun. 2026. GuruFocus rates STU:135 with a GF Score™ of 40/100 and a GF Value™ of €16.22. The stock has 3 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

SCYNEXIS's adjusted free cash flow per share for the three months ended in Jun. 2026 was €-1.093. Add all the adjusted free cash flow per share for the past 10 years together and divide the count will get our Cyclically Adjusted FCF per Share, which is €-44.26 for the trailing ten years ended in Jun. 2026.

During the past 3 years, the average Cyclically Adjusted FCF Growth Rate was 23.80% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted FCF Growth Rate using Cyclically Adjusted FCF per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted FCF Growth Rate of SCYNEXIS was 23.80% per year. The lowest was 23.80% per year. And the median was 23.80% per year.

As of today (2026-08-16), SCYNEXIS's current stock price is €4.84. SCYNEXIS's Cyclically Adjusted FCF per Share for the quarter that ended in Jun. 2026 was €-44.26. SCYNEXIS's Cyclically Adjusted Price-to-FCF of today is .


SCYNEXIS  (STU:135) Cyclically Adjusted FCF per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted FCF per Share may underestimate the company's free cash flow. Cyclically Adjusted Price-to-FCF can seem to be too high even the actual Price-to-Free-Cash-Flow is low.

For the Cyclically Adjusted Price-to-FCF, the free cash flow per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/FCF calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted Price-to-FCF is also called CAPFCF Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted free cash flow per share of a company over the past 10 years.


Be Aware

Cyclically Adjusted Price-to-FCF works better for cyclical companies. It gives you a better idea on the company's real free cash flow value.


SCYNEXIS Cyclically Adjusted FCF per Share Related Terms


SCYNEXIS Cyclically Adjusted FCF per Share Historical Data

* Premium members only.

The historical data trend for SCYNEXIS's Cyclically Adjusted FCF per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

SCYNEXIS Cyclically Adjusted FCF per Share Chart

SCYNEXIS Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted FCF per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 -96.04 -72.09 -54.82 -40.57

SCYNEXIS Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Cyclically Adjusted FCF per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -48.77 -62.36 -40.57 -36.92 -44.26

STU:135 vs IXHL, ETST, INIS: Cyclically Adjusted FCF per Share Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, SCYNEXIS's Cyclically Adjusted Price-to-FCF, along with its competitors' market caps and Cyclically Adjusted Price-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


SCYNEXIS Cyclically Adjusted Price-to-FCF vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, SCYNEXIS's Cyclically Adjusted Price-to-FCF distribution charts can be found below:

* The bar in red indicates where SCYNEXIS's Cyclically Adjusted Price-to-FCF falls into.


STU:135
40GF Score
SCYNEXIS Inc STU:135
Cyclically Adjusted FCF per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

SCYNEXIS Cyclically Adjusted FCF per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

What is Cyclically Adjusted FCF per Share? How do we calculate Cyclically Adjusted FCF per Share?

Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted FCF per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the free cash flow per share from 2001 through 2010.

We adjusted the 2001 free cash flow per share data with the total inflation from 2001 through 2010 to the equivalent free cash flow in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's free cash flow is $1 a share in 2001, then the 2001's equivalent free cash flow in 2010 is $1.4 a share. If Wal-Mart's free cash flow is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 free cash flow in 2010 is $1.35. So on and so forth, you get the equivalent free cash flow per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted FCF per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, SCYNEXIS's adjusted Free Cash Flow per Share data for the three months ended in Jun. 2026 was:

Adj_FreeCashFlowPerShare= Free Cash Flow per Share /CPI of Jun. 2026 (Change)*Current CPI (Jun. 2026)
=-1.093/333.9520*333.9520
=-1.093

Current CPI (Jun. 2026) = 333.9520.

SCYNEXIS Quarterly Data

Free Cash Flow per Share CPI Adj_FreeCashFlowPerShare
201609 -20.857 241.428 -28.850
201612 -14.305 241.432 -19.787
201703 -19.794 243.801 -27.113
201706 -20.337 244.955 -27.726
201709 -12.982 246.819 -17.565
201712 -12.142 246.524 -16.448
201803 -15.890 249.554 -21.264
201806 -12.121 251.989 -16.064
201809 -9.058 252.439 -11.983
201812 -9.003 251.233 -11.967
201903 -9.339 254.202 -12.269
201906 -10.309 256.143 -13.441
201909 -11.271 256.759 -14.660
201912 -14.681 256.974 -19.079
202003 -10.448 258.115 -13.518
202006 -6.286 257.797 -8.143
202009 -5.005 260.280 -6.422
202012 -8.721 260.474 -11.181
202103 -0.243 264.877 -0.306
202106 -2.944 271.696 -3.619
202109 -4.147 274.310 -5.049
202112 -6.820 278.802 -8.169
202203 -3.501 287.504 -4.067
202206 -3.249 296.311 -3.662
202209 -3.828 296.808 -4.307
202212 -3.621 296.797 -4.074
202303 -2.960 301.836 -3.275
202306 11.005 305.109 12.045
202309 1.944 307.789 2.109
202312 -1.184 306.746 -1.289
202403 -0.607 312.332 -0.649
202406 -1.664 314.175 -1.769
202409 0.113 315.301 0.120
202412 -1.555 315.605 -1.645
202503 -1.117 319.799 -1.166
202506 -1.045 322.561 -1.082
202509 -1.192 324.800 -1.226
202512 2.482 324.054 2.558
202603 -1.100 330.213 -1.112
202606 -1.093 333.952 -1.093

Add all the adjusted free cash flow per share together and divide 10 will get our Cyclically Adjusted FCF per Share.

What does a Cyclically Adjusted FCF per Share of €-44.26 mean?
SCYNEXIS (STU:135) has a Cyclically Adjusted FCF per Share of €-44.26 as of Jun. 2026. Cyclically Adjusted FCF per Share represents the company's inflation-adjusted FCF per share over a 10-year period. View historical data on SCYNEXIS and its competitors.
Is SCYNEXIS's Cyclically Adjusted FCF per Share too high?
SCYNEXIS's current Cyclically Adjusted FCF per Share is €-44.26. Overall, SCYNEXIS has a GF Score™ of 40/100, reflecting its overall financial health beyond just this single metric.
How does SCYNEXIS's Cyclically Adjusted FCF per Share compare to IXHL and ETST?
SCYNEXIS's Cyclically Adjusted FCF per Share of €-44.26 can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted FCF per Share for a Drug Manufacturers company?
A good Cyclically Adjusted FCF per Share depends on the Drug Manufacturers industry context. However, Cyclically Adjusted FCF per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted FCF per Share mean?
A high Cyclically Adjusted FCF per Share can signal that a stock is expensive relative to its fundamentals. Cyclically Adjusted FCF per Share represents the company's inflation-adjusted FCF per share over a 10-year period. View historical data on SCYNEXIS and its competitors. SCYNEXIS's current Cyclically Adjusted FCF per Share is €-44.26. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is SCYNEXIS stock overvalued right now?
SCYNEXIS (STU:135) has a current Cyclically Adjusted FCF per Share of €-44.26. The stock's GF Value™ is €16.22, compared to a current price of €4.84 — trading 70.2% below its estimated fair value. The current Cyclically Adjusted FCF per Share is €-44.26. SCYNEXIS's overall GF Score™ is 40/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted FCF per Share calculated?
Cyclically Adjusted FCF per Share is calculated from a company's financial statements. For SCYNEXIS (STU:135), the current Cyclically Adjusted FCF per Share is €-44.26 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is SCYNEXIS (STU:135) Overvalued in 2026?

Based on GuruFocus' analysis, SCYNEXIS stock appears to be undervalued. The current stock price of €4.84 is trading 70.2% below its estimated GF Value™ of €16.22.

Key valuation signals for STU:135:

  • Cyclically Adjusted FCF per Share: €-44.26
  • GF Value™: €16.22 vs. price of €4.84 (70.2% below fair value)
  • GF Score™: 40/100 with 3 warning signs

No single metric tells the full story. See the STU:135 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


SCYNEXIS Business Description

Other Exchanges SCYX:USA0L49:UK
Address 1 Evertrust Plaza, 13th Floor, Jersey City, NJ, USA, 07302 - 6548
SCYNEXIS Inc is a drug development company that focuses on the development and commercialization of novel anti-infectives to address unmet therapeutic needs. It is engaged in developing a product candidate, ibrexafungerp which is a novel oral and intravenous (IV) drug for the treatment of several fungal infections, including serious and life-threatening invasive fungal infections. The ibrexafungerp is a novel and structurally distinct triterpenoid glucan synthase inhibitor that is effective in vitro and in vivo against broad range of Candida and Aspergillus species, including drug-resistant strains as well as Pneumocystis, Coccidioides, Histoplasma and Blastomyces genera and some common mucorales species.
40GF Score

Get the complete analysis for STU:135

Cyclically Adjusted FCF per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€4.84
Price
€16.22
GF Value